Agency Information Collection Activities: Proposed Collection; Comment Request, 11540-11542 [2010-4948]
Download as PDF
<![CDATA[
11540
Federal Register / Vol. 75, No. 47 / Thursday, March 11, 2010 / Notices
TRANSACTION GRANTED EARLY TERMINATION—Continued
ET Date
25–FEB–10 ..............................................................
20100406
20100412
20100418
20100419
26–FEB–10 ..............................................................
FOR FURTHER INFORMATION CONTACT:
Sandra M. Peay, Contact Representative
Or Renee Hallman, Contact
Representative, Federal Trade
Commission, Premerger Notification
Office, Bureau of Competition, Room H–
303, Washington, DC 20580, (202) 326–
3100.
By Direction of the Commission.
Donald S. Clark,
Secretary.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
jlentini on DSKJ8SOYB1PROD with NOTICES
AGENCY: Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
SUMMARY: This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project:
‘‘Development and Evaluation of
AIIRQ’s Quality Indicators Improvement
Toolkit.’’ In accordance with the
Paperwork Reduction Act, 44 U.S.C.
3501–3520, AHRQ invites the public to
comment on this proposed information
collection.
Jkt 220001
Initiate Systems, Inc.
Samsung Electronics Co., Ltd.
Samsung Digital Imaging Co., Ltd.
Samsung Digital Imaging Co., Ltd.
GTCR Fund IX/A, L.P.
ATI Holdings, Inc.
ATI Holdings, Inc.
PepsiCo, Inc.
PepsiAmericas, Inc.
PepsiAmericas, Inc.
PepsiCo, Inc.
The Pepsi Bottling Group, Inc.
The Pepsi Bottling Group, Inc.
S.A.C. Private Equity Investors, L.P.
Spheris Holding II, Inc. a debtor-in-possession
Spheris Leasing LLC
Spheris Canada Inc.
Spheris Holding II, Inc., a debtor-in-possession
Spheris Operations LLC
Vianeta Communications
This proposed information collection
was previously published in the Federal
Register on December 31st, 2009 and
allowed 60 days for public comment.
One comment was received. The
purpose of this notice is to allow an
additional 30 days for public comment.
DATES: Comments on this notice must be
received by April 12, 2010.
Written comments should
be submitted to: AHRQ’s OMB Desk
Officer by fax at (202) 395–6974
(attention: AHRQ’s desk officer) or by
e-mail at
OIRA_submission@omb.eop.gov
(attention: AHRQ’s desk officer).
Copies of the proposed collection
plans, data collection instruments, and
specific details on the estimated burden
can be obtained from the AHRQ Reports
Clearance Officer.
BILLING CODE 6750–01–M
16:35 Mar 10, 2010
20100420
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
Party name
ADDRESSES:
[FR Doc. 2010–5172 Filed 3–10–10; 8:45 am]
VerDate Nov<24>2008
ET
req.
status
Trans. No.
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
e-mail at
doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Proposed Project
Development and Evaluation of AHRQ’s
Quality Indicators Improvement Toolkit
An important part of AHRQ’s mission
is to disseminate information and tools
that can support improvement in quality
and safety in the U.S. health care
community. See 42 U.S.C. 299(b)(1)(F);
299a(a)(1) and (2). This proposed
information collection supports that
part of AHRQ’s mission by developing
and evaluating a toolkit that will enable
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
hospitals to effectively use AHRQ’s
Quality Indicators (QIs).
AHRQ has developed sets of QIs that
can be used by the Agency and others
to document quality and safety
conditions at U.S. hospitals. Two sets of
QIs will be used in this proposed
toolkit: the Inpatient Quality Indicators
(IQIs) and the Patient Safety Indicators
(PSIs). The IQIs contain measures of
volume, mortality, and utilization for
common medical conditions and major
surgical procedures. The PSIs are a set
of measures to screen for potentially
preventable adverse events that patients
may experience during hospitalization.
These QIs have been previously
developed and evaluated by AHRQ, and
are in use at a number of hospitals
throughout the country. The QIs and
supportive documentation on how to
work with them are posted on AHRQ’s
Web site at https://
www.qualityindicators.ahrg.gov. Many
of the QIs have been endorsed by the
National Quality Forum through its
consensus review process.
Values for each QI can be estimated
for a given hospital by applying
computations in SAS programs
developed by AHRQ to the hospital’s
pre-existing inpatient encounter data.
To identify potential areas for
improving the quality and safety of the
care that a hospital provides, the
hospital can use these data to examine
its current performance on each QI
measure, changes in its performance
over time, and how its performance
compares to that of other hospitals.
However, despite the availability of the
QIs as tools to help hospitals assess
their performance, many U.S. hospitals
E:\FR\FM\11MRN1.SGM
11MRN1
11541
Federal Register / Vol. 75, No. 47 / Thursday, March 11, 2010 / Notices
have limited experience with the use of
such measurement tools, or in using
quality improvement methods to
improve their performance as assessed
by these measures.
An alpha version of the Quality
Indicators Improvement Toolkit will be
developed, which then will be field
tested by six hospitals. During the field
test, the proposed evaluation will assess
the usability of the Toolkit for hospitals,
and it will examine their experiences in
implementing interventions to improve
their performance on the AHRQ QIs, as
well as effects on trends in the
hospitals’ AHRQ QI values. Using
results from the evaluation, the alpha
Toolkit will be revised to yield a final
Toolkit that will be effective in
supporting hospitals’ quality
improvement efforts.
The development and evaluation of
the Quality Indicators Improvement
Toolkit will be conducted by AHRQ’s
contractor, the RAND Corporation,
under contract number
HHSA290200600017I. RAND has
subcontracted with the University
HealthSystem Consortium (UHC) to
partner in the development of the
Toolkit and field testing of it with
hospitals as they use the Toolkit in
carrying out initiatives designed to
improve performance on the QIs.
Method of Collection
Case study research methods will be
used for this qualitative study. The
following four data collection
instruments will be used in the
evaluation:
(1) Pre/post-test interview protocol—
Consisting of both open- and closedended questions will be administered
prior to implementation of the Toolkit
and again post implementation. The
purpose of this data collection is to
obtain data on the steps the hospitals
took to implement actions to improve
performance on the QIs; their plans for
Estimated Annual Respondent Burden
making process changes; and their
experiences in achieving changes and
perceptions regarding lessons learned
that could be shared with other
hospitals.
(2) Update protocol—Consisting of
both open- and closed-ended questions
will be administered three times during
the study (quarterly during the
implementation year). The purpose of
this data collection is to capture
longitudinal data regarding hospitals’
progress in implementing changes,
successes and challenges, and plans for
subsequent actions. These data will
include descriptive information on
changes over time in the hospitals’
implementation actions and how they
are using the Toolkit, as well as
experiential information on the
perceptions of participants regarding the
improvement implementation process
and its effects. It also ensures the
collection of information close to
pertinent events, which avoids the
recall bias associated with retrospective
reporting of experiences.
(3) Usability testing protocol—Also
consisting of both open and closed
ended questions will be administered
once at the end of the evaluation period.
The purpose of this data collection is to
gather information from the hospitals on
how they used each tool in the Toolkit,
the ease of use of each tool, which tools
were most helpful, suggested changes to
improve each tool, and suggestions for
other tools to add to the Toolkit. This
information will be used in the
revisions of the Toolkit following the
end of the field test.
(4) AHRQ QI data collection tool—
Used to collect the IQI and PSI measures
calculated by the hospitals both prior to
implementation of the Toolkit and again
post implementation. The purpose of
this data collection is to determine if the
hospitals’ implementation actions,
including use of the toolkit, had a
measurable impact on the QI measures.
Exhibit 1 shows the estimated
annualized burden hours for the
respondents’ time to participate in this
information collection. Three protocols
will be used to collect data from
respondents in interviews that will take
one hour each. The pre/post-test
interview protocol will be administered
twice—at the beginning and end of the
field-test year. The pre- test interviews
will be performed as one-hour group
interviews conducted with the six
hospitals’ implementation teams at the
start of the year. At the end of the year,
post-test interviews will be performed
as one-hour group interviews with three
of the hospitals and during site visits
with the other three hospitals. At each
site visit, data will be collected through
one-hour interviews with the hospital’s
implementation team as well as through
other group interviews performed
separately with each of the key
stakeholder groups—physicians, nurses,
clerks, and others. The additional data
from the stakeholder groups will allow
triangulation of variations in
perceptions and experiences among
different groups, of which the
implementation teams might not be
aware.
The quarterly update protocol will be
administered quarterly to 2 hospital
staff members from each hospital during
the year (in months 3, 6, and 9). The
usability testing protocol will be
administered to 4 staff members once at
the end of the evaluation period. The
AHRQ QI data collection tool will be
used both pre- and post-implementation
to collect the QI measures. The total
burden is estimated to be 360 hours.
Exhibit 2 shows the estimated
annualized cost burden associated with
the respondents’ time to participate in
the evaluation. The total cost burden is
estimated to be $9,886.
EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS
Number of
hospitals
Form name
jlentini on DSKJ8SOYB1PROD with NOTICES
Pre/Post-Test Interview Protocol .....................................................................
Quarterly Update Protocol ...............................................................................
Usability Testing Protocol ................................................................................
AHRQ QI Data Collection Tool ........................................................................
Total ..........................................................................................................
Number of
responses per
hospital
6
6
6
6
24
26
6
4
2
NA
* Includes time to program and run the computer programs necessary to produce the measures.
VerDate Nov<24>2008
16:35 Mar 10, 2010
Jkt 220001
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
E:\FR\FM\11MRN1.SGM
11MRN1
Hours per
response
1
1
1
*12
NA
Total burden
hours
156
36
24
144
360
11542
Federal Register / Vol. 75, No. 47 / Thursday, March 11, 2010 / Notices
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN FOR HOSPITALS
Number of
hospitals
Form name
Pre/Post-Interview Protocol .............................................................................
Quarterly Update Protocol ...............................................................................
Usability Testing Protocol ................................................................................
AHRQ QI Data Collection Tool ........................................................................
Total ..........................................................................................................
Total burden
hours
6
6
6
6
24
156
36
24
144
360
Average
hourly wage
rate*
$27.46
27.46
27.46
27.46
NA
Total cost
burden
$4,284
989
659
3,954
9,886
* Based upon the mean of the average wages, National Compensation Survey: Occupational wages in the United States, March 2009, ‘‘U.S.
Department of Labor, Bureau of Labor Statistics.’’ Used as an overall average wage rate across the various types of staff involved in the quality
improvements.
Estimated Annual Costs to the Federal
Government
Exhibit 3 shows the estimated total
and annualized cost of this project to
the government. The estimated total cost
for the evaluation work is $209,827 over
the two-year year project, with an
annualized total cost of $104,914. These
costs were developed based on
estimates of staff days required, to
which administrative expenses are
applied, and based on airfare, hotel, and
per diem costs for staff travel for the site
visits at the end of the evaluation.
EXHIBIT 3—ESTIMATED COST OF THE EVALUATION
Cost component
Total cost
Protocol Development .............................................................................................................................................
Data Collection Activities .........................................................................................................................................
Data Analysis ...........................................................................................................................................................
Publication of Results ..............................................................................................................................................
Travel for Site Visits ................................................................................................................................................
Total ..................................................................................................................................................................
jlentini on DSKJ8SOYB1PROD with NOTICES
Request for Comments
In accordance with the above-cited
Paperwork Reduction Act legislation,
comments on AHRQ’s information
collection are requested with regard to
any of the following: (a) Whether the
proposed collection of information is
necessary for the proper performance of
AHRQ healthcare research and
healthcare information dissemination
functions, including whether the
information will have practical utility;
(b) the accuracy of AHRQ’s estimate of
burden (including hours and costs) of
the proposed collection(s) of
information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
VerDate Nov<24>2008
16:35 Mar 10, 2010
Jkt 220001
Dated: February 24, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010–4948 Filed 3–10–10; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0121]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Mammography
Quality Standards Act Requirements
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
$40,278
91,104
45,252
24,370
8,823
209,827
Annualized
cost
$20,139
45,552
22,626
12,185
4,412
104,914
the estimated reporting and
recordkeeping burden associated with
the Mammography Quality Standards
Act requirements.
DATES: Submit written or electronic
comments on the collection of
information by May 10, 2010.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
Daniel Gittleson, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, 301–796–
5156, Daniel.Gittleson@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined in
44 U.S.C. 3502(3) and 5 CFR 1320.3(c)
and includes agency requests or
requirements that members of the public
E:\FR\FM\11MRN1.SGM
11MRN1
]]>Agencies
[Federal Register Volume 75, Number 47 (Thursday, March 11, 2010)]
[Notices]
[Pages 11540-11542]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-4948]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Agency for Healthcare Research and Quality, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the intention of the Agency for
Healthcare Research and Quality (AHRQ) to request that the Office of
Management and Budget (OMB) approve the proposed information collection
project: ``Development and Evaluation of AIIRQ's Quality Indicators
Improvement Toolkit.'' In accordance with the Paperwork Reduction Act,
44 U.S.C. 3501-3520, AHRQ invites the public to comment on this
proposed information collection.
This proposed information collection was previously published in
the Federal Register on December 31st, 2009 and allowed 60 days for
public comment. One comment was received. The purpose of this notice is
to allow an additional 30 days for public comment.
DATES: Comments on this notice must be received by April 12, 2010.
ADDRESSES: Written comments should be submitted to: AHRQ's OMB Desk
Officer by fax at (202) 395-6974 (attention: AHRQ's desk officer) or by
e-mail at OIRA_submission@omb.eop.gov (attention: AHRQ's desk
officer).
Copies of the proposed collection plans, data collection
instruments, and specific details on the estimated burden can be
obtained from the AHRQ Reports Clearance Officer.
FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427-1477, or by e-mail at
doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Proposed Project
Development and Evaluation of AHRQ's Quality Indicators Improvement
Toolkit
An important part of AHRQ's mission is to disseminate information
and tools that can support improvement in quality and safety in the
U.S. health care community. See 42 U.S.C. 299(b)(1)(F); 299a(a)(1) and
(2). This proposed information collection supports that part of AHRQ's
mission by developing and evaluating a toolkit that will enable
hospitals to effectively use AHRQ's Quality Indicators (QIs).
AHRQ has developed sets of QIs that can be used by the Agency and
others to document quality and safety conditions at U.S. hospitals. Two
sets of QIs will be used in this proposed toolkit: the Inpatient
Quality Indicators (IQIs) and the Patient Safety Indicators (PSIs). The
IQIs contain measures of volume, mortality, and utilization for common
medical conditions and major surgical procedures. The PSIs are a set of
measures to screen for potentially preventable adverse events that
patients may experience during hospitalization. These QIs have been
previously developed and evaluated by AHRQ, and are in use at a number
of hospitals throughout the country. The QIs and supportive
documentation on how to work with them are posted on AHRQ's Web site at
https://www.qualityindicators.ahrg.gov. Many of the QIs have been
endorsed by the National Quality Forum through its consensus review
process.
Values for each QI can be estimated for a given hospital by
applying computations in SAS programs developed by AHRQ to the
hospital's pre-existing inpatient encounter data. To identify potential
areas for improving the quality and safety of the care that a hospital
provides, the hospital can use these data to examine its current
performance on each QI measure, changes in its performance over time,
and how its performance compares to that of other hospitals. However,
despite the availability of the QIs as tools to help hospitals assess
their performance, many U.S. hospitals
[[Page 11541]]
have limited experience with the use of such measurement tools, or in
using quality improvement methods to improve their performance as
assessed by these measures.
An alpha version of the Quality Indicators Improvement Toolkit will
be developed, which then will be field tested by six hospitals. During
the field test, the proposed evaluation will assess the usability of
the Toolkit for hospitals, and it will examine their experiences in
implementing interventions to improve their performance on the AHRQ
QIs, as well as effects on trends in the hospitals' AHRQ QI values.
Using results from the evaluation, the alpha Toolkit will be revised to
yield a final Toolkit that will be effective in supporting hospitals'
quality improvement efforts.
The development and evaluation of the Quality Indicators
Improvement Toolkit will be conducted by AHRQ's contractor, the RAND
Corporation, under contract number HHSA290200600017I. RAND has
subcontracted with the University HealthSystem Consortium (UHC) to
partner in the development of the Toolkit and field testing of it with
hospitals as they use the Toolkit in carrying out initiatives designed
to improve performance on the QIs.
Method of Collection
Case study research methods will be used for this qualitative
study. The following four data collection instruments will be used in
the evaluation:
(1) Pre/post-test interview protocol--Consisting of both open- and
closed-ended questions will be administered prior to implementation of
the Toolkit and again post implementation. The purpose of this data
collection is to obtain data on the steps the hospitals took to
implement actions to improve performance on the QIs; their plans for
making process changes; and their experiences in achieving changes and
perceptions regarding lessons learned that could be shared with other
hospitals.
(2) Update protocol--Consisting of both open- and closed-ended
questions will be administered three times during the study (quarterly
during the implementation year). The purpose of this data collection is
to capture longitudinal data regarding hospitals' progress in
implementing changes, successes and challenges, and plans for
subsequent actions. These data will include descriptive information on
changes over time in the hospitals' implementation actions and how they
are using the Toolkit, as well as experiential information on the
perceptions of participants regarding the improvement implementation
process and its effects. It also ensures the collection of information
close to pertinent events, which avoids the recall bias associated with
retrospective reporting of experiences.
(3) Usability testing protocol--Also consisting of both open and
closed ended questions will be administered once at the end of the
evaluation period. The purpose of this data collection is to gather
information from the hospitals on how they used each tool in the
Toolkit, the ease of use of each tool, which tools were most helpful,
suggested changes to improve each tool, and suggestions for other tools
to add to the Toolkit. This information will be used in the revisions
of the Toolkit following the end of the field test.
(4) AHRQ QI data collection tool--Used to collect the IQI and PSI
measures calculated by the hospitals both prior to implementation of
the Toolkit and again post implementation. The purpose of this data
collection is to determine if the hospitals' implementation actions,
including use of the toolkit, had a measurable impact on the QI
measures.
Estimated Annual Respondent Burden
Exhibit 1 shows the estimated annualized burden hours for the
respondents' time to participate in this information collection. Three
protocols will be used to collect data from respondents in interviews
that will take one hour each. The pre/post-test interview protocol will
be administered twice--at the beginning and end of the field-test year.
The pre- test interviews will be performed as one-hour group interviews
conducted with the six hospitals' implementation teams at the start of
the year. At the end of the year, post-test interviews will be
performed as one-hour group interviews with three of the hospitals and
during site visits with the other three hospitals. At each site visit,
data will be collected through one-hour interviews with the hospital's
implementation team as well as through other group interviews performed
separately with each of the key stakeholder groups--physicians, nurses,
clerks, and others. The additional data from the stakeholder groups
will allow triangulation of variations in perceptions and experiences
among different groups, of which the implementation teams might not be
aware.
The quarterly update protocol will be administered quarterly to 2
hospital staff members from each hospital during the year (in months 3,
6, and 9). The usability testing protocol will be administered to 4
staff members once at the end of the evaluation period. The AHRQ QI
data collection tool will be used both pre- and post-implementation to
collect the QI measures. The total burden is estimated to be 360 hours.
Exhibit 2 shows the estimated annualized cost burden associated
with the respondents' time to participate in the evaluation. The total
cost burden is estimated to be $9,886.
Exhibit 1--Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Form name Number of responses per Hours per Total burden
hospitals hospital response hours
----------------------------------------------------------------------------------------------------------------
Pre/Post-Test Interview Protocol................ 6 26 1 156
Quarterly Update Protocol....................... 6 6 1 36
Usability Testing Protocol...................... 6 4 1 24
AHRQ QI Data Collection Tool.................... 6 2 *12 144
Total....................................... 24 NA NA 360
----------------------------------------------------------------------------------------------------------------
* Includes time to program and run the computer programs necessary to produce the measures.
[[Page 11542]]
Exhibit 2--Estimated Annualized Cost Burden for Hospitals
----------------------------------------------------------------------------------------------------------------
Number of Total burden Average hourly Total cost
Form name hospitals hours wage rate* burden
----------------------------------------------------------------------------------------------------------------
Pre/Post-Interview Protocol..................... 6 156 $27.46 $4,284
Quarterly Update Protocol....................... 6 36 27.46 989
Usability Testing Protocol...................... 6 24 27.46 659
AHRQ QI Data Collection Tool.................... 6 144 27.46 3,954
Total....................................... 24 360 NA 9,886
----------------------------------------------------------------------------------------------------------------
* Based upon the mean of the average wages, National Compensation Survey: Occupational wages in the United
States, March 2009, ``U.S. Department of Labor, Bureau of Labor Statistics.'' Used as an overall average wage
rate across the various types of staff involved in the quality improvements.
Estimated Annual Costs to the Federal Government
Exhibit 3 shows the estimated total and annualized cost of this
project to the government. The estimated total cost for the evaluation
work is $209,827 over the two-year year project, with an annualized
total cost of $104,914. These costs were developed based on estimates
of staff days required, to which administrative expenses are applied,
and based on airfare, hotel, and per diem costs for staff travel for
the site visits at the end of the evaluation.
Exhibit 3--Estimated Cost of the Evaluation
------------------------------------------------------------------------
Annualized
Cost component Total cost cost
------------------------------------------------------------------------
Protocol Development.................... $40,278 $20,139
Data Collection Activities.............. 91,104 45,552
Data Analysis........................... 45,252 22,626
Publication of Results.................. 24,370 12,185
Travel for Site Visits.................. 8,823 4,412
Total............................... 209,827 104,914
------------------------------------------------------------------------
Request for Comments
In accordance with the above-cited Paperwork Reduction Act
legislation, comments on AHRQ's information collection are requested
with regard to any of the following: (a) Whether the proposed
collection of information is necessary for the proper performance of
AHRQ healthcare research and healthcare information dissemination
functions, including whether the information will have practical
utility; (b) the accuracy of AHRQ's estimate of burden (including hours
and costs) of the proposed collection(s) of information; (c) ways to
enhance the quality, utility, and clarity of the information to be
collected; and (d) ways to minimize the burden of the collection of
information upon the respondents, including the use of automated
collection techniques or other forms of information technology.
Comments submitted in response to this notice will be summarized
and included in the Agency's subsequent request for OMB approval of the
proposed information collection. All comments will become a matter of
public record.
Dated: February 24, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010-4948 Filed 3-10-10; 8:45 am]
BILLING CODE 4160-90-M
